(Q44282128)

English

A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours

scientific article published on 6 June 2009

Statements

A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours (English)
Merrill J Egorin

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit